Focusing on the Apolipoprotein M–Mitophagy Axis: A Mechanism for Renal Protection in Diabetic Nephropathy
Journal of Diabetes Research · 2026-01 · 2026 (1)
DOI: 10.1155/jdr/1498605 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes Research, online erschienen am 19.03.2026. Verfasst von Tianlei Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Changzhou First People's Hospital, Changzhou, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Apolipoproteins M, Mitophagy, Mitochondria. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bethune Charitable Foundation, Changzhou City Applied Basic Research Program.
Abstract (Originalsprache)
Diabetic nephropathy (DN), a predominant cause of end‐stage renal disease (ESRD), is primarily driven bfigolic disturbances and mitochondrial dysfunction. Apolipoprotein M (ApoM), a protein associated with high‐density lipoprotein (HDL), is notably downregulated in DN and is correlated with a decline in renal function. Recent studies have identified a protective bidirectional axis between ApoM and mitophagy, the selective autophagy of mitochondria. ApoM, chiefly through its role as a carrier for sphingosine‐1‐phosphate (S1P), enhances mitophagy by activating the silent information regulator 1 (SIRT1) and parkin induced kinase 1 (PINK1)/Parkin pathways, thereby improving mitochondrial quality control. Conversely, mitophagy facilitates ApoM synthesis by supplying sufficient adenosine triphosphate (ATP) for its production and the assembly of HDL. In the context of DN, hyperglycemia disrupts this reciprocal relationship, leading to a detrimental cycle of impaired mitophagy and reduced ApoM, which exacerbates renal injury. Targeting the ApoM–mitophagy axis through ApoM enhancement or mitophagy activation emerges as a promising therapeutic approach for personalized renal protection in DN. This review synthesizes the mechanistic interplay between lipid metabolism and mitochondrial quality control, emphasizing its translational potential and the necessity for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Changzhou First People's Hospital, Changzhou, China.
ORCID-Profile: Tianlei Chen, Min Yang
Förderung
- Bethune Charitable Foundation
- Changzhou City Applied Basic Research Program
Zitieren
APA
Chen, T., & Yang, M. (2026). Focusing on the Apolipoprotein M–Mitophagy Axis: A Mechanism for Renal Protection in Diabetic Nephropathy. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/1498605
Vancouver
Chen T, Yang M. Focusing on the Apolipoprotein M–Mitophagy Axis: A Mechanism for Renal Protection in Diabetic Nephropathy. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/1498605
BibTeX
@article{Chen2026,
author = {Chen, Tianlei and Yang, Min},
title = {Focusing on the Apolipoprotein M–Mitophagy Axis: A Mechanism for Renal Protection in Diabetic Nephropathy},
journal = {Journal of Diabetes Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jdr/1498605}
}
EUVIMED